MedPath

Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method

Not Applicable
Conditions
Acceptance Processes
Interventions
Other: Group A, who will complete a questionnaire before receiving information about intrauterine devices
Other: Group B who will answer a questionnaire after having the information about the intrauterine devices
Registration Number
NCT05317715
Lead Sponsor
Raincy Montfermeil Hospital Group
Brief Summary

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice, in France, use of the IUD is still "reserved" for older women or those who have already had children, despite medical recommendations.

In this study the investigator will investigate whether clear information about the mode of action and insertion/withdrawal of IUDs would dispel these misconceptions of patients.

Detailed Description

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice in France, the use of IUDs is still "reserved" for older women or those who have already had children, despite medical recommendations. Indeed, there is a certain feeling of mistrust towards the IUD as a contraceptive method. Sometimes the patient's reasons for refusal were unclear or misconceptions and prejudices prevailed.

Various research studies and theses have identified the various obstacles to the use of the IUD as a contraceptive. Today it would be interesting to evaluate whether a short presentation of the IUD during a consultation would lead to a better acceptance of women to use it as a possible contraceptive method.

In this study the investigators will investigate whether clear information about the mode of action and insertion/removal of IUDs would dispel these misconceptions of patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Any woman aged 18 years and over who comes to a family planning centre
  • Having expressed her free and informed written consent
  • Affiliated to a social security scheme
Exclusion Criteria
  • Women under 18 years of age
  • Woman with an IUD
  • Woman who has had an IUD before
  • Woman whose reason for consultation of the day is the insertion of an IUD
  • Menopausal woman
  • Woman who is infertile for any reason
  • Illiterate woman or woman who does not read French
  • Refusal to participate in the protocol
  • Incapable of age.
  • Pregnant or breastfeeding women
  • Vulnerable persons and protected persons as provided for in the Public Health Code Public Health Code (articles L. 1121-5 to L.1121-8 and L.1122-1-2).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
without device informationGroup A, who will complete a questionnaire before receiving information about intrauterine devicesthis group of patients will complete a questionnaire before receiving information on contraceptive intrauterine devices (copper or hormonal)
with device informationGroup B who will answer a questionnaire after having the information about the intrauterine devicesThis group of patients will receive information about contraceptive intrauterine devices (copper or hormonal) before completing a questionnaire
Primary Outcome Measures
NameTimeMethod
Rate of acceptance of the IUD as a possible contraceptive methodday 1

measuring the acceptance rate of the intrauterine device as a potential contraceptive method

Secondary Outcome Measures
NameTimeMethod
Basic knowledge of intrauterine devicesday 1

verification of Basic knowledge of intrauterine devices

Trial Locations

Locations (1)

Le Raincy Montfermeil hospital

🇫🇷

Montfermeil, France

© Copyright 2025. All Rights Reserved by MedPath